Evidence map›Paper›PMID 27704168›Full record

ArticleEuropean journal of clinical pharmacology2017

Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission.

Daniel Sevilla-Sanchez, Núria Molist-Brunet, Jordi Amblàs-Novellas, Pere Roura-Poch, Joan Espaulella-Panicot, Carles Codina-Jané

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Factors Associated with the Detection of Inappropriate Prescriptions in Older People: A Prospective Cohort.International journal of environmental research and public health · 2021
    Observational
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel Sevilla-SanchezHospital Universitari de Vic, Hospital de la Santa Creu de Vic, Vic, Barcelona, Spain. danielsevillasanchez@gmail.com.ORCID http://orcid.org/0000-0003-2993-6200
Núria Molist-BrunetHospital Universitari de Vic, Hospital de la Santa Creu de Vic, Vic, Barcelona, Spain.
Jordi Amblàs-NovellasHospital Universitari de Vic, Hospital de la Santa Creu de Vic, Vic, Barcelona, Spain.
Pere Roura-PochHospital Universitari de Vic, Hospital de la Santa Creu de Vic, Vic, Barcelona, Spain.
Joan Espaulella-PanicotHospital Universitari de Vic, Hospital de la Santa Creu de Vic, Vic, Barcelona, Spain.
Carles Codina-JanéHospital Universitari de Vic, Hospital de la Santa Creu de Vic, Vic, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdverse drug events (ADEs) lead to adverse clinical outcomes such as hospitalization. There is little information about the characteristics of ADEs in patients with advanced chronic conditions and have a prognosis of limited life expectancy. This study aimed to evaluate (i) the prevalence of ADEs at the time of admission to hospital, (ii) the causality, severity, and preventability of the ADEs, and (iii) the clinical and pharmacological characteristics associated with the ADEs.

methodsThis is a prospective cross-sectional study (county of Osona, Catalonia, Spain). We included patients who required palliative care as identified by the NECPAL CCOMS-ICO tool who were hospitalized in an acute geriatric unit (AGU). A system of alerts (trigger tool) was used together with a multidisciplinary review for the detection of the ADEs.

resultsOver the course of 10 months, 235 patients were recruited. Seventy-six ADEs affecting 24.68 % of the sample were identified, and of these, 23 (30.26 % of the ADEs; 8.51 % of the sample) were directly related to hospitalization. The multivariate logistic regression analysis identified the following risk factors: presence of extreme polypharmacy (≥10 medications) (OR = 3.02; 95 % CI = 1.48-6.19), anticholinergic burden according to the Anticholinergic Drug Scale (ADS) (OR = 2.32; 95 % CI = 1.13-4.78), and treatment complexity according to the Medication Regimen Complexity Index (MRCI) scale (OR = 2.90; 95 % CI = 1.44-5.83). The vast majority (94.45 %) of the ADEs were considered to be preventable. There were no differences in the survival of the patients.

conclusionsADEs are common, largely preventable, and implicated in the hospitalization of patients who require palliative care.

Indexed as

AgedAged, 80 and overCholinergic AntagonistsChronic DiseaseCross-Sectional StudiesDrug-Related Side Effects and Adverse ReactionsFemaleHospitalizationHumansInappropriate PrescribingLife ExpectancyMalePalliative CarePolypharmacyPrevalencePrognosisCholinergic AntagonistsAdverse drug eventsChronic diseaseEnd-of-lifeHospital admissionPalliative carePolypharmacy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.